Retracted Article: Prediction of the Survival Status, Immunotherapy Response, and Medication of Lung Adenocarcinoma Patients Based on Hypoxia- and Apoptosis-Related Genes
Hormone and Metabolic Research · 01.01.2025 · 57 (01) · 55-66
DOI: 10.1055/a-2458-7088 ↗Kurz gefasst
Zurückgezogene Publikation in der Zeitschrift Hormone and Metabolic Research, erschienen am 01.01.2025. Verfasst von Ziliang Shi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Thoracic Surgery, The Affiliated Anyang Tumor Hospital of Henan University of Science and Technology, Anyang, China. Hauptthemen laut MEDLINE: Adenocarcinoma of Lung, Apoptosis, Immunotherapy, Lung Neoplasms. Die Arbeit nennt 40 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Thoracic Surgery, The Affiliated Anyang Tumor Hospital of Henan University of Science and Technology, Anyang, China.
Zitieren
APA
Shi, Z., Sang, Z., Xiao, J., Hou, J., & Geng, M. (2025). Retracted Article: Prediction of the Survival Status, Immunotherapy Response, and Medication of Lung Adenocarcinoma Patients Based on Hypoxia- and Apoptosis-Related Genes. Hormone and Metabolic Research, 57(01), 55-66. https://doi.org/10.1055/a-2458-7088
Vancouver
Shi Z, Sang Z, Xiao J, Hou J, Geng M. Retracted Article: Prediction of the Survival Status, Immunotherapy Response, and Medication of Lung Adenocarcinoma Patients Based on Hypoxia- and Apoptosis-Related Genes. Hormone and Metabolic Research. 2025;57(01):55-66. doi:10.1055/a-2458-7088
BibTeX
@article{Shi2025,
author = {Shi, Ziliang and Sang, Zi and Xiao, Junmeng and Hou, Jianbin and Geng, Mingfei},
title = {Retracted Article: Prediction of the Survival Status, Immunotherapy Response, and Medication of Lung Adenocarcinoma Patients Based on Hypoxia- and Apoptosis-Related Genes},
journal = {Hormone and Metabolic Research},
year = {2025},
volume = {57},
number = {01},
pages = {55--66},
doi = {10.1055/a-2458-7088}
}
EUVIMED